Screening of tumor suppressor genes on 1q31.1-32.1 in Chinese patients with sporadic colorectal cancer

Chinese Medical Journal

Volumn 121, Issue 24, 2008, Pages 2479-2486

  Zhou, Chong Zhi ^a   Qiu, Guo Qiang ^a   Wang, Xiao Liang ^a   Fan, Jun Wei ^a   Tang, Hua Mei ^a   Sun, Yu Hao ^a   Wang, Quan ^a   Huang, Fei ^a   Yan, Dong Wang ^a   Li, Da Wei ^a   Peng, Zhi Hai ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

CSRP1; Loss of heterozygosity; Sporadic colorectal cancer; Tumor suppressor gene

Indexed keywords

COMPLEMENT FACTOR H RELATED 3; CYSTEINE AND GLYCINE RICH PROTEIN 1; LEIOMODIN 1; PROTEIN PHOSPHATASE 1 REGULATORY SUBUNIT 12B; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CHINESE; CHROMOSOME 1Q; CHROMOSOME ANALYSIS; CLINICAL FEATURE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DNA DETERMINATION; DNA SEQUENCE; DOWN REGULATION; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCATION; GENE MAPPING; GENETIC MARKER; GENETIC RISK; GENETIC SCREENING; HETEROZYGOSITY LOSS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MICROSATELLITE MARKER; NUCLEOTIDE SEQUENCE; PATIENT INFORMATION; TUMOR SUPPRESSOR GENE;

EID: 60649086213     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200812020-00003     Document Type: Article

References (34)

1. Rougier P, Mitry E. Epidemiology, treatment and chemoprevention in colorectal cancer. Ann Oncol 2003; 14 Suppl 2: ii3-ii5.
2. Hawk ET, Limburg PJ, Viner JL. Epidemiology and prevention of colorectal cancer. Surg Clin North Am 2002; 82: 905-941.
3. Kinzler K, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1997; 87: 159-170.
4. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767.
5. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, et al. Allelotype of colorectal carcinomas. Science 1989; 244: 207-211.
6. Jacobs S, Thompson ER, Nannya Y, Yamamoto G, Pillai R, Ogawa S, et al. Genome-wide, high-resolution detection of copy number, loss of heterozygosity, and genotypes from formalin-fixed, paraffin-embedded tumor tissue using microarrays. Cancer Res 2007; 67: 2544-2551.
7. Shaposhnikov SA, Akopov SB, Chemov IP, Thomsen PD, Joergensen C, Collins AR, et al. A map of nuclear matrix attachment regions within the breast cancer loss-of-heterozygosity region on human chromosome 16q22.1. Genomics 2007; 89:354-361.
8. Ninomiya H, Nomura K, Satoh Y, Okumura S, Nakagawa K, Fujiwara M, et al. Genetic instability in lung cancer: concurrent analysis of chromosomal, mini- and microsatellite instability and loss of heterozygosity. Br J Cancer 2006; 94: 1485-1491.
9. Solomon E, Voss R, Hall V, Bodmer WF, Jass JR, Jeffreys AJ, et al. Chromosome 5 allele loss in human colorectal carcinomas. Nature 1987; 328: 616-619.
10. van der Boseh K, Beeker I, Savelyeva L, Bruderlein S, Sehlag P, Schwab M. Deletions in the short arm of chromosome 8 are present in up to 90% of human colorectal cancer cell lines. Genes Chromosomes Cancer 92; 5: 91-95.
11. Monpezat JP, Delattre O, Bernard A, Grunwald D, Remvikos Y, Muleris M, et al. Loss of alleles on chromosome 18 and on the short arm of chromosome 17 in polyploid colorectal carcinomas. Int J Cancer 1988; 41: 404-408.
12. Lanza G; Matteuzzi M, Gafa R, Orvieto E, Maestri I, Santini A, et al. Chromosome 18q allelic loss and prognosis in stage II and III colon cancer. Int J Cancer 1998; 79: 390-395.
13. Orita H, Sakamoto N, Ajioka Y, Terai T, Hino O, Sato N, et al. Allelic loss analysis of early-stage flat-type colorectal tumors. Ann Oncol 2006; 17: 43-49.
14. Zhou CZ, Peng ZH, Zhang F, Qiu GQ, He L. Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma. World J Gastroenterol 2002; 8: 668-673.
15. Stella A, Resta N, Gentile M, Susca F, Mareni C, Montera MP, et al. Exclusion of the APC gene as the cause of a variant form of familial adenomatous polyposis (FAP). Am J Hum Genet 1993; 53: 1031-1037.
16. Isobe M, Emanuel BS, Givol D, Oren M, Croce CM. Localization of gene for human p53 tumour antigen to band 17p13. Nature 1986; 320: 84-85.
17. Cho KR, Oliner JD, Simons JW, Hedrick L, Fearon ER, Preisinger AC, et al. The DCC gene: structuralanalysis and mutations in colorectal carcinomas. Genomics 1994; 19: 525-531.
18. Goel A, Arnold CN, Tassone P, Chang DK, Niedzwiecki D, Dowell JM, et al. Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colori cancers. Int J Cancer 2004; 112: 754-759.
19. Peng Z, Zhang F, Zhou C, Ling Y, Bai S, Liu W, et al. Genome-wide search for loss of heterozygosity in Chinese patients with sporadic colorectal cancer. Int J Gastrointest Cancer 2003; 34: 39-48.
20. Zhou CZ, Qiu GQ, Zhang F, He L, Peng ZH. Loss of heterozygosity on chromosome 1 in sporadic colorectal carcinoma. World J Gastroenterol 2004; 10: 1431-1435.
21. Vasen HF, Griffioen G, Offerhaus GJ, Den Hartog Jager FC, van Leeuwen-Comelisse IS, Meera Khan P, et al. The value of screening and central registration of families with familial adenomatous polyposis. A study of 82 families in The Netherlands. Dis Colon Rectum 1990; 33: 227-230.
22. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116: 1453-1456.
23. Zheng HT, Peng ZH, Zhou CZ, LiDP, Wang ZW, Qiu GQ, et al. Detailed deletion mapping of loss of heterozygosity on 22q13 in sporadic colorectal cancer. World J Gastroenterol 2005; 11: 1668-1672.
24. Peng Z, Zhou C, Zhang F, Ling Y, Tang H, Bai S, et al. Loss of heterozygosity of chromosome 20 in sporadic colorectal cancer. Chin Med J 2002; 115: 1529-1532.
25. Patterson TA, Lobenhofer EK, Fulmer-Smentek SB, Collins PJ, Chu TM, Bao W, et al. Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project, Nat Biotechnol 2006; 24: 1140-1150.
26. Guo Y, Guo H, Zhang L, Xie H, Zhao X, Wang F, et al. Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells. J Virol 2005, 79: 14392-14403.
27. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002; 30: e15.
28. Benitez J, Osorio A, Barroso A, Arranz E, Diaz-Guillen MA, Robledo M, et al. A region of allelic imbalance in 1q31-32 in primary breast cancer coincides with a recombination hot spot. Cancer Res 1997; 57: 4217-4220.
29. Pietseh T, Koch A, Wiestler OD. Molecular genetic studies in medulloblastomas: evidence for tumor suppressor genes at the chromosomal regions 1q31-32 and 17p13. Klin Padiatr 1997; 209: 150-155.
30. Kitamura Y, Shimizu K, Tanaka S, Ito K, Emi M. Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q. Genes Chromosomes Cancer 2000; 27: 244-251.
31. Dube JY, Chapdelaine P, Trahan PL, Deperthes D, Frenette G, Tremblay RR. Abundant cysteine-rich protein-1 is localized in the stromal compartment of the human prostate. Arch Androl 1998; 40: 109-115.
32. Yu TS, Moctezuma-Anaya M, Kubo A, Keller G, Robertson S. The heart LIM protein gene (H1p), expressed in the developing and adult heart, defines a new tissue-specific LIM-only protein family. Mech Dev 2002; 116: 187-192.
33. Hirasawa Y, Arai M, Imazeki F, Tada M, Mikata R, Fukai K, et al. Methylation status of genes upregulated by demethylating agent 5-aza-2′-deoxycytidine in hepatocellular carcinoma. Oncology 2006; 71: 77-85.
34. Dong Q, Ludgate M, Vassart G. Cloning and sequencing of a novel 64-kDa autoanfigen recognized by patients with autoimmune thyroid disease. J Clin Endocrinol Metab 1991; 72: 1375-1381.